<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2F667752-ABE0-4914-9C97-82F42CC11C60"><gtr:id>2F667752-ABE0-4914-9C97-82F42CC11C60</gtr:id><gtr:name>University of Greenwich</gtr:name><gtr:address><gtr:line1>Old Royal Naval College</gtr:line1><gtr:line2>Park Row</gtr:line2><gtr:line3>Greenwich</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE10 9LS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C6D0044A-2CD2-4167-B90B-922AF53E361F"><gtr:id>C6D0044A-2CD2-4167-B90B-922AF53E361F</gtr:id><gtr:name>University of Kent</gtr:name><gtr:address><gtr:line1>The Registry</gtr:line1><gtr:line4>Canterbury</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT2 7NZ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3E584F9-4583-484D-A1E1-3A891E3CD32C"><gtr:id>E3E584F9-4583-484D-A1E1-3A891E3CD32C</gtr:id><gtr:name>Dartford and Gravesham NHS Trust</gtr:name><gtr:address><gtr:line1>Darent Valley Hospital</gtr:line1><gtr:line2>Darenth Wood Road</gtr:line2><gtr:postCode>DA2 8DA</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FB5D6522-20EB-4EF7-B531-9DACC59C5706"><gtr:id>FB5D6522-20EB-4EF7-B531-9DACC59C5706</gtr:id><gtr:name> University of Pavia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6ED98605-E2D0-401D-A73F-A9923F6C5D9D"><gtr:id>6ED98605-E2D0-401D-A73F-A9923F6C5D9D</gtr:id><gtr:name>East Kent Hospitals University NHS Foundation Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C6D0044A-2CD2-4167-B90B-922AF53E361F"><gtr:id>C6D0044A-2CD2-4167-B90B-922AF53E361F</gtr:id><gtr:name>University of Kent</gtr:name><gtr:department>Medway School of Pharmacy</gtr:department><gtr:address><gtr:line1>The Registry</gtr:line1><gtr:line4>Canterbury</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT2 7NZ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C6D0044A-2CD2-4167-B90B-922AF53E361F"><gtr:id>C6D0044A-2CD2-4167-B90B-922AF53E361F</gtr:id><gtr:name>University of Kent</gtr:name><gtr:address><gtr:line1>The Registry</gtr:line1><gtr:line4>Canterbury</gtr:line4><gtr:line5>Kent</gtr:line5><gtr:postCode>CT2 7NZ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2F667752-ABE0-4914-9C97-82F42CC11C60"><gtr:id>2F667752-ABE0-4914-9C97-82F42CC11C60</gtr:id><gtr:name>University of Greenwich</gtr:name><gtr:address><gtr:line1>Old Royal Naval College</gtr:line1><gtr:line2>Park Row</gtr:line2><gtr:line3>Greenwich</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE10 9LS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3E584F9-4583-484D-A1E1-3A891E3CD32C"><gtr:id>E3E584F9-4583-484D-A1E1-3A891E3CD32C</gtr:id><gtr:name>Dartford and Gravesham NHS Trust</gtr:name><gtr:address><gtr:line1>Darent Valley Hospital</gtr:line1><gtr:line2>Darenth Wood Road</gtr:line2><gtr:postCode>DA2 8DA</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FB5D6522-20EB-4EF7-B531-9DACC59C5706"><gtr:id>FB5D6522-20EB-4EF7-B531-9DACC59C5706</gtr:id><gtr:name> University of Pavia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6ED98605-E2D0-401D-A73F-A9923F6C5D9D"><gtr:id>6ED98605-E2D0-401D-A73F-A9923F6C5D9D</gtr:id><gtr:name>East Kent Hospitals University NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6212EF08-C9ED-4322-B0D3-9997F5A6CD1F"><gtr:id>6212EF08-C9ED-4322-B0D3-9997F5A6CD1F</gtr:id><gtr:firstName>Ruey Leng</gtr:firstName><gtr:surname>Loo</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1002151"><gtr:id>599B6FD6-8474-4C6C-8464-E03B60A6B967</gtr:id><gtr:title>Urinary metabolic phenotyping of diet-cardiovascular disease risk associations: the OmniHeart feeding trial</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1002151</gtr:grantReference><gtr:abstractText>A diet rich in complex carbohydrates from fruit/vegetables, grain/legumes, nuts/seeds, reduced in sugar, saturated fat, total fat, cholesterol and sodium (the DASH diet), has been shown to prevent and reduce high blood pressure. However, we do not completely understand which aspects of the diet are beneficial, or the biological mechanisms of its effects on high blood pressure. This has limited our ability to prevent and treat high blood pressure and its complications, which include heart disease and stroke. OmniHeart was a large (159 people) controlled feeding study, in which each participant consumed three different healthy diets (each for six weeks) with different proportion of carbohydrate, protein or unsaturated fat. Blood pressure, serum cholesterol and weight were measured during and after each dietary period, and associations of each diet with those factors were assessed. Urine specimens were also collected. The current proposal is to analyse the stored urine specimens using state-of-the art biochemical methods to obtain a metabolic fingerprint specific to each individual at each dietary period. These fingerprints, together with other clinical measurements, are to be analysed using mathematical models to identify urinary metabolites relate to the three OmniHeart diets and their effects on blood pressure and other clinical measurements. Individuals? responses to dietary interventions are to be compared to their metabolite patterns in order to identify markers that predict individual responses to the diet. This may enable doctors in the future to recommend the best specific eating pattern for each of their patients, producing maximum benefit in the reduction in blood pressure and other major risk factors. 
This proposal has the potential to improve the health of individuals and populations by advancing our understanding of how diet influences blood pressure and other major heart disease risk factors. These findings could lead to new recommendations for individuals, and enhanced future public healthy policy.</gtr:abstractText><gtr:technicalSummary>Cardiovascular diseases (CVD) contribute to half of the total chronic disease deaths worldwide. The global burden of CVD remains high despite established prevention/control measures for cardiovascular risk factors, such as evidence-based dietary (e.g. DASH diet) and pharmacologic recommendations for adverse blood pressure (BP) treatment. Urgent efforts are needed to advance understanding of the dietary components/metabolic pathways that underly the beneficial effects on BP, and serum lipids of DASH-type diets (i.e. diets rich in complex carbohydrates from fruit/vegetables, grain/legumes, nuts/seeds, reduced in sugar, saturated fat, total fat, cholesterol and sodium intake). This proposal aims to improve understanding of diet-disease risk associations via metabolic phenotyping of the stored urine specimens from a controlled feeding study with a randomised, 3-period crossover design comparing three interventions based on the DASH diet, each intervention with varying amounts of carbohydrate, protein or unsaturated fat, the OmniHeart Trial (N=159). Identification of diet-related urinary phenotypes from OmniHeart and urinary biomarkers for BP/other CVD risk factors will be achieved by integration of the dietary data from OmniHeart with the 1H-NMR analysed urinary metabolite data using multivariate data analysis techniques. In addition, inter-individual differences in metabolic phenotypes and responses to the three dietary interventions are to be explored, in an effort to detect factors potentially explaining inter-individual differences in CVD risk factor responses to the dietary interventions. Targeted biochemical characterisation and quantitation of candidate urinary biomarkers are to be undertaken, and associations of biomarker excretion and BP levels are to be assessed to advance our understanding of the aetiopathogenesis of adverse BP. 
The proposed study have unique potential to yield new insights into metabolic pathways underlying diet-CVD risk factor associations at the population and individual level. Its results may identify potential therapeutic targets that may inform future public health policy.</gtr:technicalSummary><gtr:fund><gtr:end>2015-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-10-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>389122</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kent</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Sport &amp; Exercise Sciences</gtr:department><gtr:description>Sport Science Kent</gtr:description><gtr:id>4ADF8717-4011-4D06-846B-A090B086A309</gtr:id><gtr:impact>PhD studentship will start in Feb/Mar 2016.</gtr:impact><gtr:outcomeId>56bb664e1b0755.64652488-1</gtr:outcomeId><gtr:partnerContribution>PhD studentship, intellectual input</gtr:partnerContribution><gtr:piContribution>Intellectual input, instrument facility</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Greenwich</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Science Greenwich</gtr:department><gtr:description>MMRG</gtr:description><gtr:id>7FD06E1F-1E81-4953-8154-32C9857C76E3</gtr:id><gtr:impact>Secured funding for a PhD studentshiop
Joint publication (23888060)
In 2014, we successfully developed and validated a new method for high throughput quantitative analysis of amino acids in urine sample. We have submitted a method paper to Journal of Chromatography B.</gtr:impact><gtr:outcomeId>PcfaBFNdikQ-1</gtr:outcomeId><gtr:partnerContribution>Access and training on equipment (NMR, UPLC-SYNAPT-MS) .</gtr:partnerContribution><gtr:piContribution>Sharing software facilities; Sharing data analysis methods; Intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Childhood obesity</gtr:description><gtr:id>21FFE108-09AF-45E7-B3AC-545C7952D046</gtr:id><gtr:impact>This is an initial collaboration. We are applying for funding together at the moment.</gtr:impact><gtr:outcomeId>58b9aad17f3951.03752095-1</gtr:outcomeId><gtr:partnerContribution>Sweden - provide expertise in bioinformatics
Italy - provide expertise in clinical nutritional, samples</gtr:partnerContribution><gtr:piContribution>Provide expertise in metabolic phenoytping, analysis of samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>East Kent Hospitals University NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Renal Services East Kent Hospitals University</gtr:department><gtr:description>East Kent NHS</gtr:description><gtr:id>B706EAC5-636D-4BB8-B223-8B6D359CB149</gtr:id><gtr:impact>MD student registered and started this work in Sept 2013</gtr:impact><gtr:outcomeId>PWBXLVmokfY-1</gtr:outcomeId><gtr:partnerContribution>Access to specimens; Access to patient information</gtr:partnerContribution><gtr:piContribution>Acquired NMR urine profiles; Acquired UPLC-MS urine profiles; Data analysis; Intellectual input</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kent</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medway School of Pharmacy</gtr:department><gtr:description>Pharmacy practice</gtr:description><gtr:id>184F46AE-54CC-459D-94BD-EB8F6DE11B8A</gtr:id><gtr:impact>An oral and a poster presentation at the annual Royal Pharmaceutical Society annual conference (2013). 
 Both abstracts have been published in International Journal of Pharmacy Practice Supplement. 
Submitted an abstract to the Health Services Research &amp;amp; Pharmacy Practice Conference 2015. 
Two papers published in 2016</gtr:impact><gtr:outcomeId>RXpci35n3yw-1</gtr:outcomeId><gtr:partnerContribution>Questionnaire desgin</gtr:partnerContribution><gtr:piContribution>Intellectual input; Data collection; Data analysis</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kent</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Bioscience</gtr:description><gtr:id>63852C3A-51C0-447F-9D20-C4D160AC6920</gtr:id><gtr:impact>Jointly supervised a MD student. This started in Oct 2014</gtr:impact><gtr:outcomeId>5458a5e8213462.67401792-1</gtr:outcomeId><gtr:partnerContribution>Access to spectrometer</gtr:partnerContribution><gtr:piContribution>Intellectual input in metabolic profiling; Data processing and analysis on metabolic profiling based studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kent</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Durrell Institute of Conservation and Ecology (DICE)</gtr:department><gtr:description>glomerulas disease in mouse model</gtr:description><gtr:id>88ACB6DB-D8EB-4997-A481-135D2078D070</gtr:id><gtr:impact>Collaboration in discussion about a potential project (assessing the urinary profile of mouse with glomerular disease)</gtr:impact><gtr:outcomeId>58ad69b85f33d4.14505501-1</gtr:outcomeId><gtr:partnerContribution>samples from mouse model</gtr:partnerContribution><gtr:piContribution>provide metabolic phenotyping expertise</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Nutritional study</gtr:description><gtr:id>1FED5B5D-B32F-4CB2-ADCD-BF0A97DFFFFE</gtr:id><gtr:impact>Joint publication (Pubmed ID 22952656 ).
Submitted an abstract to annual Metabolomics conference in 2012. Abstract was selected for oral presentation at the conference. 
In 2014:Abstracts submitted to 1) Metabolomic Conference and 2) American Heart Association Annual Conference. Abstract was selected for poster presentation for Metabolomic Conference (2 posters) and American Heart Association Annual Conference (one poster).</gtr:impact><gtr:outcomeId>Hweofzv15uV-1</gtr:outcomeId><gtr:partnerContribution>Provided samples and intellectual input</gtr:partnerContribution><gtr:piContribution>Acquired and analysed samples from a study; Intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Dartford and Gravesham NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Darren Valley</gtr:description><gtr:id>8CA8D3EE-C9AC-4B0B-AD36-8B5B7B05113E</gtr:id><gtr:impact>We have a MD student recruiting recurrent kidney stone patients and control.</gtr:impact><gtr:outcomeId>5458a37b099997.45822921-1</gtr:outcomeId><gtr:partnerContribution>Access to patients group; Clinical Input</gtr:partnerContribution><gtr:piContribution>Intellectual input into the research; Provide access for NMR to generate urinary metabolic profiling</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pavia</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Childhood obesity</gtr:description><gtr:id>5FD23A7D-F9EA-4431-86DC-A0279F973C5A</gtr:id><gtr:impact>This is an initial collaboration. We are applying for funding together at the moment.</gtr:impact><gtr:outcomeId>58b9aad17f3951.03752095-2</gtr:outcomeId><gtr:partnerContribution>Sweden - provide expertise in bioinformatics
Italy - provide expertise in clinical nutritional, samples</gtr:partnerContribution><gtr:piContribution>Provide expertise in metabolic phenoytping, analysis of samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>East Kent Hospitals University NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>OAB</gtr:description><gtr:id>07BCE60A-9C25-4267-98A0-00191BB54676</gtr:id><gtr:impact>Started data collection for a study. Currently we have collected the data for about 50 patients with OAB. We also recruited different group of patients e.g. UTI patients.</gtr:impact><gtr:outcomeId>RhVYEFmkbmb-1</gtr:outcomeId><gtr:partnerContribution>Access to unique group of patient (clinial data and samples)</gtr:partnerContribution><gtr:piContribution>Metabolic profiling; Data analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>East Kent Hospitals University NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Renal Services East Kent Hospitals University</gtr:department><gtr:description>Renal group</gtr:description><gtr:id>06433887-779B-4ED6-8301-926BC9FF311F</gtr:id><gtr:impact>Secured funding for PhD scholarship (Kent 50th anniversary scholarship scheme). 
Student presented a poster at the Experimental Biology 2013 and abstract publised in FASEB journal</gtr:impact><gtr:outcomeId>GGwTVHTFDKu-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input in the renal physiology</gtr:partnerContribution><gtr:piContribution>Intellectual input in the metabonomics</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Kent partnership event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>73479D55-AAC8-4E2F-B574-D44022EA5A78</gtr:id><gtr:impact>Approximately 200 delegates attended the event. Delegates were predominately health care professionals but also included researchers and research students. The title of my presentation: from clinical pharmacy to personalised healthcare. This event was held in Medway on the 28th June 2012, as part of the Athena Swan session.

1) Met researchers and healthcare professionals from different fields. 
2) Promoted the involvement of women in science.</gtr:impact><gtr:outcomeId>sGunosnXQLj</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Aurora</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8250FA64-F8B5-407F-A317-F6DFBF68F79B</gtr:id><gtr:impact>Approximately 180 female academics (predominantly universities from South East region) took part in the first day of the traininig day. The first training day was held in ILEC centre, 7th Nov. Four more training days will be held over the next few months. Other training days in different (Scotland, Manchester and Bristol) will also be held over the next few months.

Activities will be carried out atdifferrent universities to promote female leader within higher education</gtr:impact><gtr:outcomeId>hrSZB2FsSd9</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.lfhe.ac.uk/en/programmes-events/you/aurora/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Data Analysis workshop (Pretoria, South Africa)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E34E9DD8-27F7-4EF2-8493-D0FDDC434514</gtr:id><gtr:impact>Postgraduate students, post doctoral researcher and professors (approximately 30 participants in total) attended the 4 days workshop on data analysis. The SHOCSY algorithm which we have developed were also introduced to the audience and have sparked interest in using the data analysis techniques</gtr:impact><gtr:outcomeId>58ad7212415bd9.22130109</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.acgt.co.za/simca-metabolomics-data-analysis-workshop-is-hosted-in-gauteng.php</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kent renal group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>39C29D6F-2432-40F9-A426-328E04A1110B</gtr:id><gtr:impact>This meeting was mainly attended by nephrologists and biochemistry analysts in Kent area. Title of presentation: Can Biomarkers Discovery and Metabonomics Help in Understanding Cardiovascular and Renal Diseases?

1) Generate interest in metabonomics among the participants 
2) Successful joint application for a PhD scholarship.</gtr:impact><gtr:outcomeId>c8J3QNMfj1k</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>University Visit (Northwestern Univerisity)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>415088F4-9A22-407A-AE7E-0F2917E6A1CF</gtr:id><gtr:impact>Presentation of the results from OmniHeart Study and discussion of possible collaboration by applying metabolic phenotyping on the available datasets</gtr:impact><gtr:outcomeId>58ad72df030957.19983466</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IMU workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>57A203DF-B942-4D74-B174-8C90FA6AA485</gtr:id><gtr:impact>This is a metabonomics workshop organised by International Medical University (IMU), Malaysia, . The workshop was held in IMU and Puncak Alam (Campus of University Teknoglogy MARA), from 12th to 14th September 2012. I was invited to chair 2 of the sessions. The objectives of this workshop were to introduce Malaysia research community to metabonomic approaches and to highlight practical issues in conducting such research. Approximately 30 researchers registered to this workshop

1)To promote interest in my research field.
2)Attendees were keen to apply metabonomic approaches to their research.</gtr:impact><gtr:outcomeId>fkPCWnz4ZrJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>53000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kent 50th anniversary scholarship scheme</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>University of Kent</gtr:fundingOrg><gtr:id>E3BE9C9C-7DB9-43D8-8125-2436007347BC</gtr:id><gtr:outcomeId>rN6yn3kAGbP</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Vice Chancellor's PhD Scholarship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>University of Greenwich</gtr:fundingOrg><gtr:id>3094419F-3803-4CE6-B0B0-341E8512D787</gtr:id><gtr:outcomeId>AhTJP1c1Wy5</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Faculty of Science Research Fund 2014/15</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>University of Kent</gtr:fundingOrg><gtr:id>2E530FCB-E29C-4A20-A779-CCF328A427CF</gtr:id><gtr:outcomeId>5458a6c07a2ef9.63030720</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>R01</gtr:description><gtr:end>2021-01-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:fundingRef>R01HL135486</gtr:fundingRef><gtr:id>68B3E81E-6D88-4D95-A4C4-5DFFDA5D03B2</gtr:id><gtr:outcomeId>58ad66c8e79043.92299063</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>ASCLAN is a clustering approach which aims to reliably distinguish discriminatory metabolites from non-discriminatory metabolites within metabonomic datasets that contains two biological classes.</gtr:description><gtr:id>9D22446D-12E3-4089-88E6-CAC2DD6484BE</gtr:id><gtr:impact>I have requests to access the data analysis algorithm which we have directed the users to the URL below</gtr:impact><gtr:outcomeId>58ad73cbf314d5.36366000</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ASCLAN</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://www.msp.ac.uk/about/staff/clinical-professional/loo_ruey-leng_asclan.html</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>The Statistical HOmogeneous Cluster SpectroscopY (SHOCSY) is a new data analysis approach that was developed by our group. The SHOCSY is intended for analysing NMR metabonomics datasets but it is particularly useful when the dataset shows high variation within the group. This method enable us to identify individuals showing homogenous responses and those showing indifferent responses.</gtr:description><gtr:id>16D89212-D519-49CD-901D-CD964FD9A90A</gtr:id><gtr:impact>Request for using the SHOCSY received from researcher. This algorithm is now freely available to download from the website within our research group.</gtr:impact><gtr:outcomeId>5458aa921b4e57.35302218</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SHOCSY</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>http://www.msp.ac.uk/about/staff/clinical-professional/loo_ruey-leng_shocsy.html</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed a targetted analysis for 20 amino acids by LC-MS. This method is faster than standard method, where it typically requires about 90 mins per sample.</gtr:description><gtr:id>7D8FAA2E-7B87-47FF-B74E-0CF14B62AD47</gtr:id><gtr:impact>We have developed a new high throughput quantitative analysis of amino acids using HILIC UPLC-MS. This method was validated and fulfilled the FDA requirement of analytical and biologic methods. This paper has been recently published in Amino Acids</gtr:impact><gtr:outcomeId>HNDsTDKrvwi</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Targetted AA analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The UPLC-MS equipment in the University has been used for 'traditional' chemistry work. However, we have applied and validated a global profiling method using this equipment.</gtr:description><gtr:id>81B37C4D-9333-4793-9101-848F805C1C47</gtr:id><gtr:impact>This provides global profiling facilites by MS in this region.</gtr:impact><gtr:outcomeId>qQf58YixpfX</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Global profiling by LC-MS</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a novel data analysis strategy to reduce the variation in the dataset and thus generate a reliable multivariate model statistics and enhance robust biomarkers selection. These are very important aspects of 'omics' studies.</gtr:description><gtr:id>AFAFCC91-4231-4711-A493-2FAF561D89D1</gtr:id><gtr:impact>This data analysis technique may be applied to other spectroscopic data and other 'omics' type of data. We recently published this work in Analytical Chemistry. The data analysis algorithm is freely available in the public domain.</gtr:impact><gtr:outcomeId>fJGEPtphtwm</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>SHOCSY</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.msp.ac.uk/about/staff/clinical-professional/loo_ruey-leng_shocsy.html</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a novel data analysis strategy to for variable selection in the metabolic profiling studies. This work has been recently submitted to the Analytical Chemistry.</gtr:description><gtr:id>8DB98BDD-8A9A-41FB-8364-0B55C9482CC0</gtr:id><gtr:impact>Paper currently under review.</gtr:impact><gtr:outcomeId>56bb68c1ad4a65.45721232</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>ASCLAN</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>The Statistical HOmogeneous Cluster SpectroscopY (SHOCSY) is a new data analysis approach that was developed by our group. The SHOCSY is intended for analysing NMR metabonomics datasets but it is particularly useful when the dataset shows high variation within the group.</gtr:description><gtr:id>9EFC2209-10DC-49FD-B264-0F05594FF95C</gtr:id><gtr:impact>Request from researchers to access the data analysis algorithm</gtr:impact><gtr:outcomeId>5458ac3b65b140.00407129</gtr:outcomeId><gtr:title>SHOCSY</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.msp.ac.uk/about/staff/clinical-professional/loo_ruey-leng_shocsy.html</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput><gtr:softwareAndTechnicalProductOutput><gtr:description>ASCLAN is a clustering approach which aims to reliably distinguish discriminatory metabolites from non-discriminatory metabolites within metabonomic datasets that contains two biological classes.</gtr:description><gtr:id>D2B22499-2476-4AC2-98E5-A14611C8C2B6</gtr:id><gtr:impact>Request from users for accessing the algorithm. They have been referred to the URL below</gtr:impact><gtr:outcomeId>58ad772d692ab1.69224768</gtr:outcomeId><gtr:title>ASCLAN</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.msp.ac.uk/about/staff/clinical-professional/loo_ruey-leng_asclan.html</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CC6F0B9F-02F1-4B78-9B30-74B919BCA20F</gtr:id><gtr:title>Automatic Spectroscopic Data Categorization by Clustering Analysis (ASCLAN): A Data-Driven Approach for Distinguishing Discriminatory Metabolites for Phenotypic Subclasses.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/323327f946161a4d54706803fcf93469"><gtr:id>323327f946161a4d54706803fcf93469</gtr:id><gtr:otherNames>Zou X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>585d35e33f30c9.41060579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80A1BC04-8D0E-448F-9573-3787040BB070</gtr:id><gtr:title>Live kidney slices present a novel method for delineating the mechanisms of calcineurin inhibitor-mediated nephrotoxicity</gtr:title><gtr:parentPublicationTitle>FASEB JOURNAL</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec1804746ac50328eb66f377003a2f2c"><gtr:id>ec1804746ac50328eb66f377003a2f2c</gtr:id><gtr:otherNames>Kelly Mark</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>obniK98r14j</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6516E261-E841-431D-91A0-E667E6FF69A8</gtr:id><gtr:title>Assessment of the adherence to local guideline for the use of atorvastatin 80mg for patients newly diagnosed with acute coronary syndrome (ACS)</gtr:title><gtr:parentPublicationTitle>Royal Pharmaceutical Society Annual Conference</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9da3e840765accb9613418bd6d7c41bf"><gtr:id>9da3e840765accb9613418bd6d7c41bf</gtr:id><gtr:otherNames>Loo RL, Prior P, Gammie S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>inM8sEagDNc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4693B4D7-7FE9-446B-A219-4622AECBF9C1</gtr:id><gtr:title>A comparison of self-reported analgesic use and detection of urinary ibuprofen and acetaminophen metabolites by means of metabonomics: the INTERMAP Study.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fe03e5b13dd2dc6a244ce6a6a935bdc"><gtr:id>3fe03e5b13dd2dc6a244ce6a6a935bdc</gtr:id><gtr:otherNames>Loo RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>pm_13555_25_22223708</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8374CD8E-252E-470D-A7C2-0BE12E28AE59</gtr:id><gtr:title>Development and validation of an ultra-performance liquid chromatography quadrupole time of flight mass spectrometry method for rapid quantification of free amino acids in human urine.</gtr:title><gtr:parentPublicationTitle>Amino acids</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7298b99b1b49260c0e3da46130d84716"><gtr:id>7298b99b1b49260c0e3da46130d84716</gtr:id><gtr:otherNames>Joyce R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0939-4451</gtr:issn><gtr:outcomeId>56bb647fe48e43.31449021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F8D742A-8B21-480F-AF3E-2F7B20FC149C</gtr:id><gtr:title>Statistical HOmogeneous Cluster SpectroscopY (SHOCSY): an optimized statistical approach for clustering of &amp;sup1;H NMR spectral data to reduce interference and enhance robust biomarkers selection.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/323327f946161a4d54706803fcf93469"><gtr:id>323327f946161a4d54706803fcf93469</gtr:id><gtr:otherNames>Zou X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>pm_540e177e177648bac</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC4F0EF4-1FF0-4714-A608-601ACE55E739</gtr:id><gtr:title>Effects of the Optimal Macro-Nutrient Intake to Prevent Heart Disease (OmniHeart) diets on urinary excretion profiles</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fe03e5b13dd2dc6a244ce6a6a935bdc"><gtr:id>3fe03e5b13dd2dc6a244ce6a6a935bdc</gtr:id><gtr:otherNames>Loo RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>5458cd937e8495.77209987</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC1E25DF-A5E4-4D18-A579-4937E4266191</gtr:id><gtr:title>Differential effects of two fermentable carbohydrates on central appetite regulation and body composition.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a401dd5da2ff4b3c5d19980acc6f7c2c"><gtr:id>a401dd5da2ff4b3c5d19980acc6f7c2c</gtr:id><gtr:otherNames>Arora T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13555_25_22952656</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8945179-484C-4F72-AC9C-E4E6D726A2C1</gtr:id><gtr:title>Metabolic phenotyping for discovery of urinary biomarkers of diet, xenobiotics and blood pressure in the INTERMAP Study: an overview.</gtr:title><gtr:parentPublicationTitle>Hypertension research : official journal of the Japanese Society of Hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/363606352a285912cf1e39a9acd2acc7"><gtr:id>363606352a285912cf1e39a9acd2acc7</gtr:id><gtr:otherNames>Chan Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0916-9636</gtr:issn><gtr:outcomeId>58ad6d5edfc619.09501810</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>208DB67F-47A3-42D7-AB86-8AAF26E1F5EE</gtr:id><gtr:title>Characterization of metabolic responses to healthy diets and association with blood pressure: application to the Optimal Macronutrient Intake Trial for Heart Health (OmniHeart), a randomized controlled study</gtr:title><gtr:parentPublicationTitle>The American Journal of Clinical Nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a890d9d3e025d8f8163f65cabb97c088"><gtr:id>a890d9d3e025d8f8163f65cabb97c088</gtr:id><gtr:otherNames>Loo R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a995f85d4add2.05877020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DD672FD-DADD-4DD0-BD2F-F9017915BE82</gtr:id><gtr:title>Pharmacometabonomics and personalized medicine.</gtr:title><gtr:parentPublicationTitle>Annals of clinical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cc2ed26a6f76348b52e5a3db452ae86"><gtr:id>1cc2ed26a6f76348b52e5a3db452ae86</gtr:id><gtr:otherNames>Everett JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0004-5632</gtr:issn><gtr:outcomeId>pm_13555_25_23888060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7AC31409-9A39-4A45-9979-1BD9019214E5</gtr:id><gtr:title>Comparison of pharmacist and public views and experiences of community pharmacy medicines-related services in England.</gtr:title><gtr:parentPublicationTitle>Patient preference and adherence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be401c9945b50c6328f8e90f354ea66a"><gtr:id>be401c9945b50c6328f8e90f354ea66a</gtr:id><gtr:otherNames>Rodgers RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1177-889X</gtr:issn><gtr:outcomeId>58ad6e74cdd6e2.90662517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3CD27AF-27FF-4B12-B68D-2381885C5F55</gtr:id><gtr:title>Public perception of medicines-related advisory services provided by pharmacy.</gtr:title><gtr:parentPublicationTitle>Royal Pharmaceutical Society Annual Conference</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61a7da9cad53370464fa63225dcf41ae"><gtr:id>61a7da9cad53370464fa63225dcf41ae</gtr:id><gtr:otherNames>Rodgers R, RL Loo, Kraska, J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>Gqjv6ffZZ2q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B9BB873-0932-4CB5-93EE-C6456D59A1CD</gtr:id><gtr:title>Medicine-related services in community pharmacy: public preferences for pharmacy attributes and promotional methods and comparison with pharmacists' perceptions.</gtr:title><gtr:parentPublicationTitle>Patient preference and adherence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f7d8e8a659a9853d66eaa7011e7ea8b"><gtr:id>1f7d8e8a659a9853d66eaa7011e7ea8b</gtr:id><gtr:otherNames>Gammie SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1177-889X</gtr:issn><gtr:outcomeId>58ad6e5e7053b9.34990761</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002151</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>